comparemela.com

Harish Dave News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SG s AUM Biosciences to list in US via SPAC merger

The deal with Mountain Crest Acquisition Corp V reflects a pre-money equity value of $400m for AUM.

United statesHarish daveVishal doshiFu weiMountain crest acquisition corpCayman islands exemptedNasdaq stock marketMountain crestSuying liuCrest acquisition

Singapore-based AUM Biosciences partners with Roche for cancer drug trial

AUM Biosciences partners with Roche for development of AUM001 in combination with anti-PD-L1 therapy in solid tumor indications

Harish daveRoche groupNon small cell lung cancerUrothelial cancerAum biosciencesSolid tumors

Singapore-based biotech company conducting clinical trials for new oral cancer drugs

SINGAPORE - A biotechnology company based in Singapore has started clinical trials for a new oral cancer drug which they said could lead to cheaper and more targeted treatment of the disease. . Read more at straitstimes.com.

Harish daveVishal doshiAgency for scienceResearcha star

AUM Biosciences Raises USD$27M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Newsoara biopharmaHarish daveVishal doshiHandok inc

AUM Biosciences announces closing of $27 million in a Series A Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

/PRNewswire/ AUM Biosciences (AUM) today announced the successful completion of $27 million series A funding round. This will fuel AUM s vision of.

Newsoara biopharmaHarish daveVishal doshiArjun oberoiHandok incSingapore based everlifeExecutive chairmanHealth care amp hospitalsBanking amp financial servicesMedical pharmaceuticalsVenture capital

vimarsana © 2020. All Rights Reserved.